Related Experiment Video
Updated: Jul 13, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.1K
Neuroinflammation in a Mouse Model of Alzheimer's Disease versus Auditory Dysfunction: Machine Learning
Daxiang Na1, Yidan Yang2, Li Xie1
1University of Rochester Medical Center.
Research Square
|October 16, 2023
Summary
Auditory dysfunction in Alzheimer's disease (AD) models is linked to neuroinflammation in auditory pathways. Early detection of auditory brainstem response (ABR) changes may indicate AD progression.
Area of Science:
- Neuroscience
- Auditory System Research
- Alzheimer's Disease Pathogenesis
Background:
- Auditory dysfunction, including central auditory hyperactivity, is observed in 5xFAD Alzheimer's disease (AD) mouse models.
- Amyloidosis in AD may causally link to auditory dysfunction, with hyperactivity correlating to plaque deposition in auditory midbrain and thalamus.
- Neuroinflammation is proposed as a link between central auditory hyperactivity and AD, but its role in the auditory pathway remains uninvestigated in amyloidosis models.
Approach:
- Machine learning was employed to classify auditory brainstem responses (ABRs) in 5xFAD mice and wild-type (WT) littermates.
- Neuroinflammation was assessed in auditory cortical, thalamic, and brainstem regions.
- Cochlear pathology and behavioral changes (fear conditioning, open field, novel object recognition) were also evaluated.
Key Points:
- Machine learning reliably classified ABRs in 6-month and 12-month-old 5xFAD mice, with Waves IV and V characteristics being key features.
- Significant microglial and astrocytic activation were observed in the inferior colliculus and medial geniculate body of 5xFAD mice at 6 months.
- Auditory inflammation was present in cortical centers but not in lower brainstem regions; no cochlear neuronal or synaptic loss was detected.
- 5xFAD mice exhibited reduced tone responses in fear conditioning tests starting at 6 months.
Conclusions:
- Serial auditory brainstem response (ABR) measurements show promise for early, cost-effective detection of neuroinflammation in auditory processing centers in AD patients.
- Central auditory hyperactivity may serve as a potential biomarker for AD progression.
- Auditory processing changes can help stratify AD patients into distinct clinical populations.

